Results
|
|
1101.
|
Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib. [electronic resource] by
- Gao, Ningning
- Zhong, Jingjing
- Wang, Xiaodong
- Jin, Zhenchao
- Li, Wang
- Liu, Yu
- Diao, Yuwen
- Wang, Zhulin
- Jiang, Wenqi
- Jin, Guangyi
Producer: 20180814
In:
Scientific reports vol. 6
Availability: No items available.
|
|
|
1102.
|
|
|
|
1103.
|
|
|
|
1104.
|
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy. [electronic resource] by
- Darb-Esfahani, Silvia
- Denkert, Carsten
- Stenzinger, Albrecht
- Salat, Christoph
- Sinn, Bruno
- Schem, Christian
- Endris, Volker
- Klare, Peter
- Schmitt, Wolfgang
- Blohmer, Jens-Uwe
- Weichert, Wilko
- Möbs, Markus
- Tesch, Hans
- Kümmel, Sherko
- Sinn, Peter
- Jackisch, Christian
- Dietel, Manfred
- Reimer, Toralf
- Loi, Sherene
- Untch, Michael
- von Minckwitz, Gunter
- Nekljudova, Valentina
- Loibl, Sibylle
Producer: 20180212
In:
Oncotarget vol. 7
Availability: No items available.
|
|
|
1105.
|
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study. [electronic resource] by
- Uncu, Dogan
- Bayoglu, Ibrahim Vedat
- Arslan, Ulku Yalcintas
- Kucukoner, Mehmet
- Artac, Mehmet
- Koca, Dogan
- Oguz, Arzu
- Demirci, Umut
- Arpaci, Erkan
- Dogan, Mutlu
- Kucukzeybek, Yuksel
- Turker, Ibrahim
- Isikdogan, Abdurrahman
- Guler, Tunc
- Zengin, Nurullah
Producer: 20160216
In:
Asian Pacific journal of cancer prevention : APJCP vol. 16
Availability: No items available.
|
|
|
1106.
|
|
|
|
1107.
|
Fingolimod sensitizes EGFR wild‑type non‑small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest. [electronic resource] by
- Ota, Kohki
- Okuma, Takashi
- Lorenzo, Alberto De
- Yokota, Ayuka
- Hino, Hirotsugu
- Kazama, Hiromi
- Moriya, Shota
- Takano, Naoharu
- Hiramoto, Masaki
- Miyazawa, Keisuke
Producer: 20191223
In:
Oncology reports vol. 42
Availability: No items available.
|
|
|
1108.
|
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas. [electronic resource] by
- Burris, Howard A
- Hurwitz, Herbert I
- Dees, E Claire
- Dowlati, Afshin
- Blackwell, Kimberly L
- O'Neil, Bert
- Marcom, Paul K
- Ellis, Matthew J
- Overmoyer, Beth
- Jones, Suzanne F
- Harris, Jennifer L
- Smith, Deborah A
- Koch, Kevin M
- Stead, Andrew
- Mangum, Steve
- Spector, Neil L
Producer: 20050830
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|
|
|
1109.
|
|
|
|
1110.
|
|
|
|
1111.
|
|
|
|
1112.
|
|
|
|
1113.
|
Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study. [electronic resource] by
- Tenori, Leonardo
- Oakman, Catherine
- Claudino, Wederson M
- Bernini, Patrizia
- Cappadona, Silvia
- Nepi, Stefano
- Biganzoli, Laura
- Arbushites, Michael C
- Luchinat, Claudio
- Bertini, Ivano
- Di Leo, Angelo
Producer: 20130318
In:
Molecular oncology vol. 6
Availability: No items available.
|
|
|
1114.
|
|
|
|
1115.
|
|
|
|
1116.
|
|
|
|
1117.
|
Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer. [electronic resource] by
- Farrugia, M K
- Sharma, S B
- Lin, C-C
- McLaughlin, S L
- Vanderbilt, D B
- Ammer, A G
- Salkeni, M A
- Stoilov, P
- Agazie, Y M
- Creighton, C J
- Ruppert, J M
Producer: 20151130
In:
Cell death & disease vol. 6
Availability: No items available.
|
|
|
1118.
|
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. [electronic resource] by
- De Cola, A
- Volpe, S
- Budani, M C
- Ferracin, M
- Lattanzio, R
- Turdo, A
- D'Agostino, D
- Capone, E
- Stassi, G
- Todaro, M
- Di Ilio, C
- Sala, G
- Piantelli, M
- Negrini, M
- Veronese, A
- De Laurenzi, V
Producer: 20160510
In:
Cell death & disease vol. 6
Availability: No items available.
|
|
|
1119.
|
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors. [electronic resource] by
- Henary, H
- George, G C
- Wheler, J
- Naing, A
- Piha-Paul, S
- Fu, S
- Mistry, R
- Zinner, R
- Kurzrock, R
- Hong, D S
Producer: 20151217
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|
|
|
1120.
|
|